Johnson & Johnson (JNJ)
151.98
+0.71
(+0.47%)
USD |
NYSE |
May 21, 09:40
Johnson & Johnson Total Liabilities (Quarterly): 101.95B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 101.95B |
December 31, 2023 | 98.78B |
September 30, 2023 | 94.83B |
June 30, 2023 | 115.28B |
March 31, 2023 | 125.10B |
December 31, 2022 | 110.57B |
September 30, 2022 | 100.52B |
June 30, 2022 | 101.37B |
March 31, 2022 | 103.65B |
December 31, 2021 | 108.00B |
September 30, 2021 | 108.96B |
June 30, 2021 | 106.86B |
March 31, 2021 | 106.72B |
December 31, 2020 | 111.62B |
September 30, 2020 | 106.22B |
June 30, 2020 | 95.40B |
March 31, 2020 | 93.72B |
December 31, 2019 | 98.26B |
September 30, 2019 | 97.31B |
June 30, 2019 | 94.33B |
March 31, 2019 | 91.07B |
December 31, 2018 | 93.20B |
September 30, 2018 | 91.08B |
June 30, 2018 | 92.48B |
March 31, 2018 | 93.37B |
Date | Value |
---|---|
December 31, 2017 | 97.14B |
September 30, 2017 | 81.68B |
June 30, 2017 | 80.88B |
March 31, 2017 | 74.58B |
December 31, 2016 | 70.79B |
September 30, 2016 | 67.60B |
June 30, 2016 | 67.34B |
March 31, 2016 | 63.58B |
December 31, 2015 | 62.26B |
September 30, 2015 | 61.71B |
June 30, 2015 | 60.90B |
March 31, 2015 | 60.71B |
December 31, 2014 | 60.61B |
September 30, 2014 | 55.51B |
June 30, 2014 | 57.15B |
March 31, 2014 | 56.75B |
December 31, 2013 | 58.63B |
September 30, 2013 | 57.13B |
June 30, 2013 | 54.66B |
March 31, 2013 | 54.68B |
December 31, 2012 | 56.52B |
September 30, 2012 | 55.19B |
June 30, 2012 | 55.32B |
March 31, 2012 | 54.83B |
December 31, 2011 | 56.56B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
93.72B
Minimum
Mar 2020
125.10B
Maximum
Mar 2023
103.97B
Average
102.80B
Median
Total Liabilities (Quarterly) Benchmarks
Amgen Inc | 87.96B |
Eli Lilly and Co | 51.05B |
Merck & Co Inc | 65.42B |
Pfizer Inc | 128.54B |
Shockwave Medical Inc | 891.99M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 171.97B |
Shareholders Equity (Quarterly) | 70.02B |
Debt to Equity Ratio | 0.4803 |
Current Ratio | 1.170 |
Net Debt Paydown Yield | 0.32% |